Bryan Wahl insider trades
Open-market stock purchases and sales by Bryan Wahl, General Counsel at Tarsus Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 2, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 19, 2026 | TARS Tarsus Pharmaceuticals, Inc | Sold | $283K |
| Mar 18, 2026 | TARS Tarsus Pharmaceuticals, Inc | Sold | $283K |
| Mar 17, 2026 | TARS Tarsus Pharmaceuticals, Inc | Sold | $284K |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 15, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
| Mar 5, 2026 | TARS Tarsus Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- TARS Tarsus Pharmaceuticals, Inc: 17 sales, last Mar 19, 2026